SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (1250)8/12/1999 11:13:00 PM
From: David Cathcart  Read Replies (1) of 1826
 
PB,

Thanks for the link. Very interesting! I would love to have been a fly on the wall in the room as SUGN execs realized that they were not holding the cards they thought they were. There are several fundamental differences between MOGN & SUGN (e.g. profitability) and I would assume the potential types of discussions between PNU & MOGN would be somewhat different than those that took place between PNU & SUGN. Whatever the case, I would think that Blitzer and Co. must be careful so as to avoid stumbling into the position of realizing, as SUGN did, that they are not in Kansas anymore. MOGN is swimming with a big fish and it could easily be swallowed up as MGI-114 nears PIII trails (assuming they are warranted).

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News